Vol 11 - N° 4 - octobre 2019
P. S455-S507© SPLF
Immunologie-oncologie thoracique
Editorial
N. Girard, M. Wislez
Rev. Mal. Respir. actual November 2019; 11(4): S455. Publication en ligne : 19 November 2019
Criteria for radiological assessment of patients on immunotherapy
E. Wasielewski, C. Gauvain, A.B. Cortot
Rev. Mal. Respir. actual November 2019; 11(4): S457. Publication en ligne : 19 November 2019
Predictive biomarkers and inhibitors of immune control points in non-small cell lung cancer
G. Birsen, D. Damotte, A. Lupo, M. Alifano, F. Goldwasser, K. Leroy, M. Wislez
Rev. Mal. Respir. actual November 2019; 11(4): S468. Publication en ligne : 19 November 2019
Oncogenic addictions and immunotherapy: Which sequence?
L. Mhanna, J. Mazières
Rev. Mal. Respir. actual November 2019; 11(4): S476. Publication en ligne : 19 November 2019
Radiotherapy and immunotherapy: New standard, new options
N. Giraud, P. Giraud
Rev. Mal. Respir. actual November 2019; 11(4): S484. Publication en ligne : 19 November 2019
Pulmonary toxicities of immunotherapies: Assess and treat
A. Canellas, L. Matton, V. Fallet, J. Cadranel
Rev. Mal. Respir. actual November 2019; 11(4): S491. Publication en ligne : 19 November 2019
The clinical art of immunotherapy: From initial management to follow-up
N. Girard
Rev. Mal. Respir. actual November 2019; 11(4): S502. Publication en ligne : 19 November 2019